To avoid Type 2 diabetes, seniors may need to watch their weight just as closely as younger individuals do, a prospective cohort study showed….
Read More »Diabetes In Control
Diabetes Care Management Program Lowers Health Care Costs, Hospitalization Rates
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds….
Read More »Adolescent BP Predicts Progression to Hypertension in Young Adulthood
Adolescent blood pressure (BP) predicts progression to hypertension in young adulthood, with teen-age boys with normal BP 3 to 4 times more likely than girls to have high BP early in adulthood, according to the results of a study….
Read More »FDA Reviews Olmesartan (Benicar) Safety Record, Cites CV Deaths in Trials
The FDA is conducting a safety review of the angiotensin receptor blocker (ARB) olmesartan (Benicar, Daiichi Sankyo) after determining that diabetic patients taking the drug in two completed phase 3 trials may have had an excess risk of cardiovascular death, the regulatory body has announced [1]….
Read More »New ACCORD Insights: Steady Glycemic Control Most Important
Epidemiologic relationships between A1c and all-Cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD Trial….
Read More »DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment
Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes, Inc., announced results from DURATION-4, the fourth in a series of studies designed to test the superiority of BYDUREON™ (exenatide extended-release for injectable suspension), an investigational Type 2 diabetes therapy, as compared to other Type 2 diabetes medications….
Read More »Experts Reach Consensus on Diabetes and Cancer Links
US experts who reviewed the emerging evidence on the links between cancer and diabetes have reported their findings in a consensus statement on the state of science linking both diseases and highlighted key questions that remain unanswered….
Read More »Insulin Peptide Points to a Solution for Type 1 Diabetes
Researchers at National Jewish Health and the University of Colorado Anschutz Medical Campus have identified the precise protein fragment, or peptide, that can trigger diabetes in mice….
Read More »Potential for Diabetes Patients to Create Their Own Insulin
Researchers have used a unique collection of pancreas specimens taken from patients who died soon after diagnosis of Type 1 diabetes to show that they respond to the ongoing process of destruction by inducing their islet cells to proliferate.…
Read More »Circadian Clock in Pancreas Linked to Diabetes
For the first time, researchers at Northwestern University have found that there also exists a circadian clock in the pancreas, which regulates the production of insulin, and that a fault in this clock could eventually cause diabetes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.